| Jared Thayer Montague, ALC, NCC | |
|
1117 22nd St S Ste 208, Birmingham, AL 35205-2813 | |
| (205) 319-6222 | |
| Not Available |
| Full Name | Jared Thayer Montague |
|---|---|
| Gender | Male |
| Speciality | Counselor |
| Location | 1117 22nd St S Ste 208, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003591751 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | ALC04482 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jared Thayer Montague, ALC, NCC 2000 2nd Ave S Apt 328, Birmingham, AL 35233-2075 Ph: (423) 440-3836 | Jared Thayer Montague, ALC, NCC 1117 22nd St S Ste 208, Birmingham, AL 35205-2813 Ph: (205) 319-6222 |
News Archive
The world's experts in nuclear explosion monitoring teamed up with pharmaceutical producers from across the globe in Brussels, Belgium, from 12 to 14 May 2015, to address a growing challenge to nuclear test monitoring.
Scientists at UC San Francisco have found a more precise way to turn off genes, a finding that will speed research discoveries and biotech advances and may eventually prove useful in reprogramming cells to regenerate organs and tissues.
Errors in diagnosis place a heavy financial burden on an already costly health care system and can be devastating for affected patients. Strengthening certain aspects of a new and evolving model of comprehensive and coordinated primary care could potentially address this highly relevant, but underemphasized safety concern, say Mark Graber, M.D., of Stony Brook University Medical Center, and Hardeep Singh, M.D., M.P.H., of Baylor College of Medicine, in a commentary published in the July 28 issue of the Journal of the American Medical Association.
Pfizer Inc. announced today that the U.S. Food and Drug Administration's (FDA) Antiviral Drugs Advisory Committee voted (10 to 4) to recommend the approval of Selzentry (maraviroc) tablets for use in treatment-naïve adult patients with CCR5-tropic HIV-1 virus as part of combination therapy.
Scientists have just discovered a new mechanism by which HIV evades the immune system, and which shows precisely how the virus avoids elimination. The new research shows that HIV targets and disables a pathway involving a number of biological molecules that are key in blocking viral activity and clearing infection.
› Verified 6 days ago
Caroline W West, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 Vestavia Pkwy, Suite 250, Birmingham, AL 35216 Phone: 205-824-0011 | |
Monique S Johnson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1401 20th St S, Birmingham, AL 35205 Phone: 205-510-2600 Fax: 205-510-2790 | |
Ms. Laura Michelle Angers, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1401 20th St S, Birmingham, AL 35205 Phone: 205-510-2761 Fax: 205-510-2790 | |
Paige Monique Reynolds, ALC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 181 W Valley Ave # 157, Birmingham, AL 35209 Phone: 205-675-6592 Fax: 205-278-5526 | |
Ms. Jasmine Boykin, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1700 6th Ave S, Birmingham, AL 35233 Phone: 205-529-7583 | |
Taylor Gibson, LPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3504 7th Ave S, Birmingham, AL 35222 Phone: 205-918-6860 |